While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...

Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...

Pfizer Inc. has announced that the European Commission (EC) has issued a decision amending the marketing authorization for ...

The respiratory syncytial virus (RSV) infects cells along the human respiratory tract, from the nose to the lungs. Each year ...

Decoy Therapeutics Inc. has announced that a series of antiviral drug candidates previously designed by its Imp3act platform ...

Just four cases of bird flu in backyard flocks have been confirmed in this area, and risk to humans is very low. Humans can't ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...